- Home
- IQV vs RJF Comparison
IQV vs RJF Comparison
Compare IQV & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- RJF
- Stock Information
- Founded
- IQV 1982
- RJF 1962
- Country
- IQV United States
- RJF United States
- Employees
- IQV N/A
- RJF N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- RJF Investment Bankers/Brokers/Service
- Sector
- IQV Health Care
- RJF Finance
- Exchange
- IQV Nasdaq
- RJF Nasdaq
- Market Cap
- IQV 26.7B
- RJF 28.5B
- IPO Year
- IQV 2013
- RJF N/A
- Fundamental
- Price
- IQV $136.91
- RJF $145.31
- Analyst Decision
- IQV Buy
- RJF Buy
- Analyst Count
- IQV 20
- RJF 12
- Target Price
- IQV $226.80
- RJF $157.64
- AVG Volume (30 Days)
- IQV 2.6M
- RJF 965.2K
- Earning Date
- IQV 05-06-2025
- RJF 04-23-2025
- Dividend Yield
- IQV N/A
- RJF 1.38%
- EPS Growth
- IQV 0.26
- RJF 25.52
- EPS
- IQV 7.35
- RJF 10.38
- Revenue
- IQV $15,497,000,000.00
- RJF $13,567,000,000.00
- Revenue This Year
- IQV $5.40
- RJF $8.75
- Revenue Next Year
- IQV $5.21
- RJF $4.98
- P/E Ratio
- IQV $18.65
- RJF $14.00
- Revenue Growth
- IQV 2.84
- RJF 13.41
- 52 Week Low
- IQV $134.65
- RJF $104.24
- 52 Week High
- IQV $252.88
- RJF $174.32
- Technical
- Relative Strength Index (RSI)
- IQV 36.95
- RJF 50.14
- Support Level
- IQV $137.34
- RJF $150.98
- Resistance Level
- IQV $145.78
- RJF $154.77
- Average True Range (ATR)
- IQV 5.73
- RJF 2.66
- MACD
- IQV -0.53
- RJF -0.31
- Stochastic Oscillator
- IQV 10.35
- RJF 36.85
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About RJF Raymond James Financial Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company supports more than 8,000 employee and independent contractor financial advisors across the United States, Canada, and the United Kingdom with over $1.5 trillion of assets under administration as of September 2024. Approximately 90% of the company's revenue is from the US and 70% is from the company's wealth-management segment.